Glucagon pre-filled pen
Indication
Treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.
Green (Restricted)
Brand:
Ogluo
Nice TA:
Commissioning responsibility:
CCG (HRG included)
PbR excluded:
No
BNF chapter:
Endocrine system
Background
Prescribing of Ogluo devices should be reserved for patients for whom the preparation and administration of conventional glucagon kits presents a barrier to effective treatment of hypoglycaemia and a risk to patient welfare.
Recommendation
LSCMMG Recommendation:
Green (Restricted)
Reason for decision:
Suitable for initiation in primary care in line with restrictions
Supporting documents: